0
Skip to Content
Arima Genomics
Clinical Tests
Biopharma Partnerships
Translational Science
Technology
Research Products ↗
About
News
Contact
Arima Genomics
Clinical Tests
Biopharma Partnerships
Translational Science
Technology
Research Products ↗
About
News
Contact
Clinical Tests
Biopharma Partnerships
Translational Science
Technology
Research Products ↗
Folder: Company
Back
About
News
Contact
Publication Erin Davis 2/20/26 Publication Erin Davis 2/20/26

Hi-C for genome-wide detection of enhancer-hijacking rearrangements in routine lymphoid cancer biopsies

Wu, et al.
Cell Genomics. 6(5):101166.

Read More
News Article Erin Davis 1/12/26 News Article Erin Davis 1/12/26

How A New 3D Genomics Test Is Transforming Cancer Diagnosis and Treatment

Read More
News Article Erin Davis 1/8/26 News Article Erin Davis 1/8/26

Fox Chase Cancer Center, Arima Genomics Partner to Implement 3D DNA Analysis in Cancer Dx

Read More
Press Release Erin Davis 1/8/26 Press Release Erin Davis 1/8/26

Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care

Read More
Presentation, Poster Erin Davis 12/7/25 Presentation, Poster Erin Davis 12/7/25

Clinical use of genome-wide Hi-C sequencing for assessment of structural variants in diffuse large B-cell lymphoma.

Michaels, et al.
ASH 2025 - Orlando, FL

Read More
Poster Erin Davis 12/7/25 Poster Erin Davis 12/7/25

Hi-C FFPE sequencing analysis is highly concordant with FISH and detects additional variants informing diagnosis and treatment in diffuse large B-cell lymphoma

Xu-Monette, et al.
ASH 2025 - Orlando, FL

Read More
Poster Erin Davis 12/7/25 Poster Erin Davis 12/7/25

Application of Hi-c sequencing to detect cryptic and novel structural aberrations in lymphoid neoplasms

Rozenova, et al.
ASH 2025 - Orlando, FL

Read More
Press Release Erin Davis 12/4/25 Press Release Erin Davis 12/4/25

Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma

Read More
Poster Erin Davis 11/15/25 Poster Erin Davis 11/15/25

Cytogenetic Advances in NHL Diagnosis by Leveraging Hi-C Sequencing

Sikkink, et al.
AMP 2025 - Boston, MA

Read More
Press Release Erin Davis 11/13/25 Press Release Erin Davis 11/13/25

Arima Genomics Announces Data Presentation at the Association of Molecular Pathology 2025

Read More
News Article Erin Davis 11/7/25 News Article Erin Davis 11/7/25

Arima Genomics Aims to Replace Some FISH-Based Cancer Tests With Hi-C Sequencing Assays

Read More
Press Release Erin Davis 11/6/25 Press Release Erin Davis 11/6/25

Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year”

Read More
Press Release Erin Davis 10/15/25 Press Release Erin Davis 10/15/25

Arima Genomics Announces New Study Showing Aventa™ Lymphoma Test Resolves Diagnostic Ambiguity and Guides Care in B-Cell Lymphoma Cases

Read More
Poster Erin Davis 10/13/25 Poster Erin Davis 10/13/25

Hi-C FFPE Sequencing for Detection of Fusions and Rearrangements that are Diagnostic, Prognostic, and Therapeutic Biomarkers in Lymphoma

Hastie, et al.
Lymphoma, Leukemia & Myeloma Congress 2025 - NY, NY

Read More
Publication Erin Davis 9/16/25 Publication Erin Davis 9/16/25

Hi-C Technology Reveals Actionable Gene Fusions and Rearrangements in Diffuse Large B-Cell Lymphoma Unidentified by Conventional FISH

Liang, et al.
Genes (Basel). 16(9):1093.

Read More
Poster Erin Davis 9/9/25 Poster Erin Davis 9/9/25

Molecular Analysis of Driver Negative Lung Cancer for Rearrangements and Fusions Using a New HiC Sequencing Assay

Ricketts, et al.
2025 World Conference on Lung Cancer - Barcelona, Spain

Read More
News Article Erin Davis 9/5/25 News Article Erin Davis 9/5/25

Arima Genomics’ CEO Sets Sight On Replacing Standard Testing With 3D Genomics Lymphoma Assay

Read More
Press Release Erin Davis 9/3/25 Press Release Erin Davis 9/3/25

Arima Genomics Introduces Aventa Lymphoma Test to Resolve Diagnostic Uncertainty in B- and T-Cell Lymphomas

Read More
Poster Erin Davis 8/4/25 Poster Erin Davis 8/4/25

Aventa Lymphoma based on Hi-C FFPE Sequencing is an Alternative to FISH and Detects Additional Variants Informing Diagnosis and Therapy in Lymphomas

Hastie, et al.
16th Annual Meeting of the Cancer Genomics Consortium - Houston, TX

Read More
Poster Erin Davis 8/4/25 Poster Erin Davis 8/4/25

Aventa FusionPlus based on Hi-C FFPE Sequencing Detects Fusions Genome-Wide with High Sensitivity in Solid Tumors

Hastie, et al.
16th Annual Meeting of the Cancer Genomics Consortium - Houston, TX

Read More
Newer Posts
Older Posts

Clinical Tests

Biopharma Partnerships
Translational Science
Technology

Research Products
↗
About
News

Contact
Privacy Policy
Terms of Use